<DOC>
	<DOCNO>NCT00223717</DOCNO>
	<brief_summary>Supine hypertension common problem affect least 50 % patient primary autonomic failure . Supine hypertension severe , complicate treatment orthostatic hypotension . Drugs use treatment orthostatic hypotension ( eg , fludrocortisone pressor agent ) , worsen supine hypertension . High blood pressure may also cause target organ damage group patient . The pathophysiologic mechanism cause supine hypertension patient autonomic failure define . In study , , investigator Vanderbilt University , examine 64 patient AF , 29 pure autonomic failure ( PAF ) 35 multiple system atrophy ( MSA ) . 66 % patient supine systolic ( systolic blood pressure [ SBP ] &gt; 150 mmHg ) diastolic ( diastolic blood pressure [ DBP ] &gt; 90 mmHg ) hypertension ( average blood pressure [ BP ] : 179 ± 5/89 ± 3 mmHg 21 PAF 175 ± 5/92 ± 3 mmHg 21 MSA patient ) . Plasma norepinephrine ( 92 ± 15 pg/mL ) plasma renin activity ( 0.3 ± 0.05 ng/mL per hour ) low subset patient AF supine hypertension . ( Shannon et al. , 1997 ) . Our group show residual sympathetic function contributes supine hypertension patient severe autonomic failure effect prominent patient MSA PAF ( Shannon et al. , 2000 ) . MSA patient mark depressor response low infusion rate trimethaphan , ganglionic blocker ; response PAF patient variable . At 1 mg/min , trimethaphan decrease supine SBP 67 +/- 8 12 +/- 6 mmHg MSA PAF patient , respectively ( P &lt; 0.0001 ) . MSA patient supine hypertension also great SBP response oral yohimbine , central alpha2 receptor blocker , PAF patient . Plasma norepinephrine decrease group , heart rate change either group . This result suggest residual sympathetic activity drive supine hypertension MSA ; contrast , supine hypertension PAF . It hop study emerge complete picture supine hypertension autonomic failure . Understanding mechanism paradoxical hypertension set profound loss sympathetic function improve approach treatment hypertension autonomic failure , could also contribute understand hypertension general .</brief_summary>
	<brief_title>Treatment Supine Hypertension Autonomic Failure</brief_title>
	<detailed_description>1 . Overnight Medication Trials : Patients study GCRC 150 mEq/day sodium balance diet free substance interfere catecholamine determination . Subjects ask use bathroom empty bladder 8:00 PM . They give randomly choose medication aliskiren ( Tekturna ) 150-300mg po , bosentan ( Tracleer ) 62.5 -125 mg po , captopril 25-50mg po , carbidopa 25-200mg po , clonidine 0.1-0.2mg po , desmopressin 0.2 - 0.6mg po ( DDAVP ) , -diltiazem 30-60 mg po , dipyridamole 200 mg aspirin 25 mg po ( Aggrenox ) , eplerenone ( Inspra ) 50-100 mg po , guanfacine ( Tenex ) 1-3 mg po , hydralazine 10-50 mg po , hydrochlorothiazide 12.5-100 mg po , L- arginine 6-17 g po , losartan 25-100mg po , metoprolol tartrate ( Lopressor ) 25-100 mg po , nebivolol hydrochloride ( Bystolic ) 2.5-40 mg po , nitroglycerin-transdermal 0.05-0.2 mg patch , nifedipine ( adalat ) dose 10-30 mg , prazosin hydrochloride 0.5-1 mg po , sildenafil ( Viagra ) 25- 100 mg po , tamsulosin hydrochloride ( Flomax ) 0.4-0.8 mg po . The combination desmopressin 0.2 mg po ( DDAVP ) nitroglycerin-transdermal 0.05-0.2 mg . The combination desmopressin 0.2 mg po nifedipine ( 10-30 mg ) . A placebo pill skin patch do control measure supine blood pressure without medication intervention . They ask lie head bed elevated 10 degree . An automated blood pressure cuff ( Dinamap ) wrap around upper arm blood pressure measure automatically 2 time row every 2 hour . At 8 AM follow morning study end . The subject stand bedside motionless possible 30 minute blood pressure heart rate determination . Urine collect 24 hour determination volume sodium , potassium catecholamine ( medication trial ) 12 hour segment , 8 a.m. 8 p.m. 8 p.m. 8 a.m. ascertain medication affect urine production . For medication trial affect renal Na and/or water regulation ( e.g . desmopressin , carbidopa ) , blood sample collect ( 5 mL , 1 teaspoon ) 8 PM 8 AM determination basic metabolic panel . Raising head bed night non-pharmacologic measure may reduce supine blood pressure , nocturnal natriuresis improve orthostatic hypotension follow morning autonomic failure patient supine hypertension . However , know tilt bed head well raise head bed . To compare effect two way raise head bed nighttime blood pressure nocturnal natriuresis , patient undergo two additional test . On two separate night ( either consecutive ) , patient receive placebo assign simple randomization lie one two different bed position : 1 . The head bed elevated 10 degree ( ~ 7 inch ) ; 2 . The whole bed tilt head-up 5 degree reverse trendelenburg ( head bed elevate ~7 inch ) . Blood pressure , orthostatic tolerance 8 AM urine collection perform describe . 2 . Blood Pressure Lowering Effect Local Heat Stress Supine Hypertension : Heat stress due high environmental temperature lower blood pressure autonomic failure patient . The mechanisms underlying phenomenon fully understood could associate 2 factor : First , heart stress likely increase core temperature patient population heat dissipation impair due inability sweat . Second , autonomic failure patient lack compensatory sympathetic splanchnic vasoconstriction tachycardia normally maintain blood pressure response heat stress healthy subject . We hypothesize , therefore , even moderate level local heat stress lower blood pressure patient autonomic failure supine hypertension . We propose pilot study evaluate effect local ( abdominal ) heat stress blood pressure autonomic failure patient , something previously do , assess potential use treatment supine hypertension This pilot study optional conducted patient already enrol `` Evaluation Treatment Autonomic Failure '' medication trial part protocol . Subjects study supine position two study day ( without heat stress ) . Each study day last ~3 hour . Core body skin temperature monitor throughout study use ingestible telemetry pill dermal patch . Blood pressure heart rate measure intermittently automate blood pressure sphygmomanometer wrap around upper arm . Segmental body fluid shift estimate use bioelectrical Impedance hemodynamic parameter use body impedance rebreathing test ( Innocor ) . After obtain normothermic baseline measurement , apply passive heat-stress commercial heating pad cover abdomen part torso provide local heating ~44ºC continuously 2 hr . Outcome measurement obtain 1 2 hour passive heat-stress , CBT increase ~1ºC baseline , whichever occur first . For control ( non-heating ) study day , heat pad apply patient turn , data collection perform one-hour interval 2 hour , provide time control . 3 . Circadian Hemodynamic Changes Autonomic Failure Patients Supine Hypertension : This study optional conducted patient already enrol `` Evaluation Treatment Autonomic Failure '' medication trial part protocol . A separate consent form ( addendum ) provide . In present study , propose following : 1 . Monitor BP HR patient AF supine hypertension 24-hour period , include fix period supine rest day , strict control physical activity , meal , water ingestion confound factor . This allow u learn intrinsic circadian variation BP patient without influence `` external factor '' . 2 . Characterize hemodynamic change underlie dip phenomenon morning BP surge , 3 . Assess change plasma volume ( measure change hematocrit ) , calculate plasma osmolality hormone regulate blood pressure blood volume , order learn mechanism responsible dipping phenomenon morning BP surge autonomic failure patient supine hypertension . These parameter compare circadian rhythm body temperature , marker central circadian rhythm , determine whether diurnal change synchronize circadian pacemaker . The duration study day 24 hour start time day . Typically , study start ~ 8AM . Therapeutic trial orthostatic hypotension and/or supine hypertension well study procedure relate mentioned protocol may perform participate study . If overnight medication trial perform study , patient may offer participate second study day without medication .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Pure Autonomic Failure</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Dipyridamole</mesh_term>
	<mesh_term>Aspirin , Dipyridamole Drug Combination</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Captopril</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Diltiazem</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<mesh_term>Hydralazine</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Bosentan</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>Patients autonomic failure supine hypertension race All medical student Pregnant woman Highrisk patient ( e.g . heart failure , symptomatic coronary artery disease , liver impairment , history stroke myocardial infarction ) History serious allergy asthma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Supine Hypertension</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Treatment</keyword>
	<keyword>Autonomic failure</keyword>
	<keyword>Pure autonomic failure</keyword>
	<keyword>Multiple System Atrophy</keyword>
	<keyword>Shy-Drager Syndrome</keyword>
</DOC>